An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Experimental Drug Acquiring Traction Online
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these profiles directly for supplier links, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and claims of rapid UK delivery. Vendors market the drug there before redirecting buyers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Voice Worries
However, physicians and chemists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in users administering products of unknown origin.
Some experts stated the demand for the experimental drug could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.
Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, advertising, and customer regulations, risking fines, legal action or prison.
Platform Response and Content Removal
Based on TikTok, the platform has taken down violative content and prohibited related keywords and search suggestions. The company said it was dedicated to keeping the service secure and allocating resources in enhancing compliance measures.
Digital Marketplace Operations
Investigations also found communities with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, filled with photos of slimming results, glowing reviews and step-by-step instructions for mixing or administering at home.
After moments of entering one community, a seller shared contact information, where most transactions occur. The vendor sent an instruction manual and guaranteed delivery within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about weight, medical conditions or previous experience.
Product Details and Costs
Inside these groups, posts display black plastic parcels with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When questioned how long a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for Telegram said it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering substances they cannot confirm. Even if the research behind retatrutide is valid, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has previously seen patients harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject users to possibly serious health risks”.
